Zobrazeno 1 - 10
of 229
pro vyhledávání: '"Francesco Onida"'
Autor:
Nicoletta Del Papa, Silvia Cavalli, Andrea Rindone, Francesco Onida, Giorgia Saporiti, Antonina Minniti, Maria Rosa Pellico, Claudia Iannone, Giorgia Trignani, Nicoletta D’Angelo, Manuel Sette, Raffaella Greco, Claudio Vitali, Roberto Caporali
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-10 (2024)
Abstract Background Autologous haematopoietic stem cell transplantation (AHSCT) is more effective than conventional immunosuppressive therapies (CIT) in improving the outcome of patients with rapidly progressive diffuse cutaneous systemic sclerosis (
Externí odkaz:
https://doaj.org/article/5c4ae2c1609e4fdc8b9283e078126e30
Autor:
Silvia Alberti Violetti, Marco Ardigò, Paolo Fava, Giuseppe Gritti, Erika Morsia, Francesco Onida, Marco Paulli, Alessandro Pileri, Pietro Quaglino, Serena Rupoli, Miriam Teoli, Pamela Vezzoli
Publikováno v:
Drugs in Context, Vol 13, Pp 1-12 (2024)
Topical chlormethine (CL) gel formulation was approved by the EMA in 2017 for the treatment of adult patients with mycosis fungoides (MF). To expand the knowledge on the management of patients with MF, this paper provides an overview of clinical prac
Externí odkaz:
https://doaj.org/article/aed28a1f55c146c2979e660ab38f79d2
Autor:
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, Fabian Müller, Riccardo Saccardi, Fermin Sanchez-Guijo, Georg Schett, Basil Sharrack, John A. Snowden, Karin Tarte, Francesco Onida, Isabel Sánchez-Ortega, Joachim Burman, Cristina Castilla Llorente, Ricard Cervera, Fabio Ciceri, Andrea Doria, Jörg Henes, James Lindsay, Andreas Mackensen, Paolo A. Muraro, Elena Ricart, Montserrat Rovira, Tsila Zuckerman, Ibrahim Yakoub-Agha, Dominique Farge
Publikováno v:
EClinicalMedicine, Vol 69, Iss , Pp 102476- (2024)
Summary: Autoimmune diseases (ADs) are characterized by loss of immune tolerance, high chronicity, with substantial morbidity and mortality, despite conventional immunosuppression (IS) or targeted disease modifying therapies (DMTs), which usually req
Externí odkaz:
https://doaj.org/article/37f79e467f134663b50770b17fc8402f
Autor:
Tamara K. Moyo, Jason H. Mendler, Raphael Itzykson, Ashwin Kishtagari, Eric Solary, Adam C. Seegmiller, Aaron T. Gerds, Gregory D. Ayers, Amy E. Dezern, Aziz Nazha, Peter Valent, Arjan A. van de Loosdrecht, Francesco Onida, Lisa Pleyer, Blanca Xicoy Cirici, Raoul Tibes, Klaus Geissler, Rami S. Komrokji, Jing Zhang, Ulrich Germing, David P. Steensma, Daniel H. Wiseman, Michael Pfeilstöecker, Chiara Elena, Nicholas C. P. Cross, Jean-Jacques Kiladjian, Michael Luebbert, Ruben A. Mesa, Guillermo Montalban-Bravo, Guillermo F. Sanz, Uwe Platzbecker, Mrinal M. Patnaik, Eric Padron, Valeria Santini, Pierre Fenaux, Michael R. Savona, On Behalf of the MDS/MPN International Working Group
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-15 (2022)
Abstract Background Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) comprise several rare hematologic malignancies with shared concomitant dysplastic and proliferative clinicopathologic features of bone marrow failure and propensity of acute l
Externí odkaz:
https://doaj.org/article/7f2429ebc64243c3b202c0776a5e62a4
Autor:
Kai Rejeski, Raffaella Greco, Francesco Onida, Isabel Sánchez-Ortega, Chiara Bonini, Anna Sureda, John Gribben, Ibrahim Yakoub-Agha, Marion Subklewe
Publikováno v:
HemaSphere, Vol 7, p e63003a8 (2023)
Externí odkaz:
https://doaj.org/article/21beba14b37a494fa6ddc80cc3cbd921
Autor:
Domenico Russo, Nicola Polverelli, Marika Vezzoli, Stella Santarone, Luca Castagna, Francesco Onida, Stefania Bramanti, Roberto Sorasio, Angelo Michele Carella, Attilio Olivieri, Calogero Vetro, Germana Beltrami, Antonio Curti, Massimo Stefano Luca Bernardi, Valentina Mancini, Pellegrino Musto, Elisabetta Terruzzi, Piero Galieni, Cristina Skert, Luisa Giaccone, Raffaella Cerretti, Erika Borlenghi, Mirko Farina, Alessandro Leoni, Simona Bernardi, Stefano Calza, Angela Gheorghiu, Michele Malagola, Massimo Martino, Fabio Ciceri
Publikováno v:
HemaSphere, Vol 7, p e4820082 (2023)
Externí odkaz:
https://doaj.org/article/5f496303c5be4b7183f7bcec5bbf0834
Autor:
Daniela Clerici, Carmine Liberatore, Paola Maria Rancoita, Chiara Maria Dellacasa, Francesca Patriarca, Paolo Corradini, Riccardo Saccardi, Angelo Michele Carella, Stella Santarone, Maurizio Musso, Anna Paola Iori, Patrizia Chiusolo, Francesco Onida, Nicola Mordini, Marco De Gobbi, Piero Galieni, Mario Luppi, Massimo Aglietta, Daniele Vallisa, Gabriella Storti, Luca Facchini, Jacopo Peccatori, Annalisa Ruggeri, Raffaella Greco, Consuelo Corti, Francesca Bonifazi, Fabio Ciceri
Publikováno v:
HemaSphere, Vol 7, p e987614b (2023)
Externí odkaz:
https://doaj.org/article/957da9c224994ecd8cf28d1dc6581af9
Autor:
Marianna Morani, Fausto Baldanti, Fabio Ciceri, Franco Citterio, Mariano Ferraresso, Corrado Girmenia, Umberto Maggiore, Massimo Martino, Francesco Onida, Luciano Potena, Fabio Vistoli, Paolo Antonio Grossi
Publikováno v:
AboutOpen, Vol 10, Iss 1 (2023)
Background: Cytomegalovirus (CMV) infection usually occurs asymptomatically but can represent an important cause of morbidity and mortality in patients with compromised immune system such as transplant patients. Infection may not respond to standard
Externí odkaz:
https://doaj.org/article/4a3a2b26fda44dc2ad428b68501f6e73
Autor:
Kai Rejeski, Raffaella Greco, Francesco Onida, Isabel Sánchez-Ortega, Chiara Bonini, Anna Sureda, John G. Gribben, Ibrahim Yakoub-Agha, Marion Subklewe
Publikováno v:
HemaSphere, Vol 7, Iss 5, p e889 (2023)
Hematological toxicity represents the most common grade ≥3 toxicity after chimeric antigen receptor (CAR) T-cell therapy. However, its underlying pathophysiology is incompletely understood and its grading and management remains ill-defined. To info
Externí odkaz:
https://doaj.org/article/227c6b423e7b4927bf4310bcb2ec78ef
Autor:
Mariarita Sciumè, Alessandro Bosi, Marta Canzi, Giusy Ceparano, Fabio Serpenti, Pasquale De Roberto, Sonia Fabris, Elena Tagliaferri, Francesca Cavallaro, Francesco Onida, Nicola Stefano Fracchiolla
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionCombination of venetoclax and hypomethylating agents (HMAs) has become a standard of care in acute myeloid leukemia (AML) aged >75 years or who have comorbidities that preclude intensive induction chemotherapy.MethodsWe conducted a monoce
Externí odkaz:
https://doaj.org/article/7eccb9fe5cf14ac58a1076e5029f5e62